Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Liabilities and Shareholders Equity (2017 - 2026)

enVVeno Medical has reported Liabilities and Shareholders Equity over the past 4 years, most recently at $10.5 million for Q4 2020.

  • For Q4 2020, Liabilities and Shareholders Equity rose 206.85% year-over-year to $10.5 million; the TTM value through Dec 2020 reached $24.1 million, up 9.84%, while the annual FY2020 figure was $10.5 million, 206.85% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2020 was $10.5 million at enVVeno Medical, up from $7.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $10.5 million in Q4 2020 and troughed at $2.2 million in Q4 2017.
  • A 4-year average of $5.4 million and a median of $5.5 million in 2018 define the central range for Liabilities and Shareholders Equity.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 206.85% in 2020 and fell as far as 49.53% in 2020.
  • Year by year, Liabilities and Shareholders Equity stood at $2.2 million in 2017, then skyrocketed by 60.71% to $3.6 million in 2018, then decreased by 3.52% to $3.4 million in 2019, then surged by 206.85% to $10.5 million in 2020.
  • Business Quant data shows Liabilities and Shareholders Equity for NVNO at $10.5 million in Q4 2020, $7.0 million in Q3 2020, and $3.7 million in Q2 2020.